Free Trial

Crinetics Pharmaceuticals (CRNX) Insider Trading & Ownership

$53.67
+0.86 (+1.63%)
(As of 07/12/2024 ET)

Crinetics Pharmaceuticals (NASDAQ:CRNX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.00%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$26.82 M
Get CRNX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Crinetics Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CRNX Insider Buying and Selling by Quarter

Crinetics Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/10/2024Stephen F BetzInsiderSell3,000$48.55$145,650.00  
7/5/2024James HassardInsiderSell15,000$44.08$661,200.00  
7/3/2024Dana PizzutiInsiderSell14,375$44.87$645,006.25  
6/28/2024Marc WilsonCFOSell32,129$43.61$1,401,145.69  
6/26/2024Jeff E KnightCOOSell956$44.38$42,427.28  
6/24/2024Dana PizzutiInsiderSell9,500$45.73$434,435.00  
6/21/2024James HassardInsiderSell15,000$44.66$669,900.00  
6/10/2024Stephen F BetzInsiderSell3,000$43.86$131,580.00  
5/28/2024Stephen F BetzInsiderSell3,000$47.49$142,470.00  
5/10/2024Stephen F BetzInsiderSell3,000$49.43$148,290.00  
5/8/2024Richard Scott StruthersCEOSell107,448$49.40$5,307,931.20  
4/15/2024Dana PizzutiInsiderSell14,375$44.47$639,256.25  
4/4/2024Richard Scott StruthersCEOSell40,951$49.17$2,013,560.67  
3/28/2024Stephanie OkeyDirectorSell17,500$46.38$811,650.00  
3/22/2024Jeff E KnightCOOSell32,359$44.31$1,433,827.29  
3/20/2024Dana PizzutiInsiderSell15,089$44.06$664,821.34  
3/20/2024Matthew K FustDirectorSell60,000$44.14$2,648,400.00  
3/19/2024Marc WilsonCFOSell6,942$42.91$297,881.22  
1/25/2024Stephen F BetzInsiderSell3,000$37.26$111,780.00  
1/10/2024Stephen F BetzInsiderSell3,000$37.65$112,950.00  
1/3/2024Dana PizzutiInsiderSell14,375$35.00$503,125.00  
1/2/2024Marc WilsonCFOSell10,000$35.47$354,700.00  
12/26/2023Stephen F BetzInsiderSell3,000$35.89$107,670.00  
12/21/2023Dana PizzutiInsiderSell9,583$34.57$331,284.31  
12/11/2023Stephen F BetzInsiderSell3,000$32.87$98,610.00  
11/27/2023Stephen F BetzInsiderSell3,000$31.84$95,520.00  
11/3/2023Richard Scott StruthersCEOSell199,082$30.56$6,083,945.92  
11/1/2023Marc WilsonCFOSell10,000$28.75$287,500.00  
10/17/2023Alan Seth KrasnerInsiderSell7,000$30.00$210,000.00  
7/13/2023Richard Scott StruthersCEOSell14,157$20.35$288,094.95  
(Data available from 1/1/2013 forward)

CRNX Insider Trading Activity - Frequently Asked Questions

Who is on Crinetics Pharmaceuticals's Insider Roster?

The list of insiders at Crinetics Pharmaceuticals includes Ajay Madan, Alan Seth Krasner, Coelho Rogerio Vivaldi, Dana Pizzuti, James Hassard, Jeff E Knight, Marc Wilson, Matthew K Fust, Perceptive Advisors Llc, Richard Scott Struthers, Stephanie Okey, and Stephen F Betz. Learn more on insiders at CRNX.

What percentage of Crinetics Pharmaceuticals stock is owned by insiders?

6.00% of Crinetics Pharmaceuticals stock is owned by insiders. Learn more on CRNX's insider holdings.

Which Crinetics Pharmaceuticals insiders have been buying company stock?

The following insider purchased CRNX shares in the last 24 months: Coelho Rogerio Vivaldi ($110,300.00).

How much insider buying is happening at Crinetics Pharmaceuticals?

Insiders have purchased a total of 5,000 CRNX shares in the last 24 months for a total of $110,300.00 bought.

Which Crinetics Pharmaceuticals insiders have been selling company stock?

The following insiders have sold CRNX shares in the last 24 months: Alan Seth Krasner ($210,000.00), Dana Pizzuti ($3,350,551.95), James Hassard ($1,331,100.00), Jeff E Knight ($1,500,100.97), Marc Wilson ($2,958,739.25), Matthew K Fust ($2,767,872.00), Richard Scott Struthers ($15,225,126.50), Stephanie Okey ($811,650.00), and Stephen F Betz ($1,717,000.38).

How much insider selling is happening at Crinetics Pharmaceuticals?

Insiders have sold a total of 825,493 Crinetics Pharmaceuticals shares in the last 24 months for a total of $29,872,141.05 sold.


This page (NASDAQ:CRNX) was last updated on 7/13/2024 by MarketBeat.com Staff

From Our Partners